Proteocyte AI’s Post

Revolutionizing Oral Cancer Care with STRATICYTE Tired of the limitations of traditional oral cancer risk assessment? STRATICYTE offers a personalized, signature-based cancer prediction assay that's changing the game. Why STRATICYTE? - Superior Performance: Compares favorably with current in-market tests - Personalized Risk Assessment: Provides a 5-year risk score for each patient - Simple Integration: Easy-to-implement process, from order to results High Accuracy: Sensitivity of 97% and a NPV of 97% - Ready to take your oral cancer care to the next level? Learn more about STRATICYTE and how it can benefit your practice: https://lnkd.in/g-spwaYd #oralsurgery #oralhealth #oralsurgeon #headandneckcancer #oralcancer Ontario Dental Association (ODA) American Association of Oral and Maxillofacial Surgeons, AMERICAN ACADEMY OF ORAL MEDICINE, AMERICAN Canadian Dental Association, Canadian Association of Oral and Maxillofacial Surgeons, Straticyte™, American Academy of Otolaryngology

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics